WEDBUSH SECURITIES INC - TEVA PHARMACEUTICAL FIN LLC ownership

TEVA PHARMACEUTICAL FIN LLC's ticker is and the CUSIP is 88163VAE9. A total of 58 filers reported holding TEVA PHARMACEUTICAL FIN LLC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
WEDBUSH SECURITIES INC ownership history of TEVA PHARMACEUTICAL FIN LLC
ValueSharesWeighting
Q1 2020$740,000
-2.4%
8,0000.0%0.09%
+31.3%
Q4 2019$758,000
+4.7%
8,0000.0%0.07%
-5.6%
Q3 2019$724,000
-1.1%
8,0000.0%0.07%
-4.1%
Q2 2019$732,000
-0.8%
8,0000.0%0.07%
-6.3%
Q1 2019$738,000
+2.2%
8,0000.0%0.08%
-14.1%
Q4 2018$722,000
-3.5%
8,0000.0%0.09%
+8.2%
Q3 2018$748,000
+0.8%
8,0000.0%0.08%
-7.6%
Q2 2018$742,000
+5.8%
8,0000.0%0.09%0.0%
Q1 2018$701,000
-0.1%
8,0000.0%0.09%
+7.0%
Q4 2017$702,000
-2.6%
8,0000.0%0.09%
-8.5%
Q3 2017$721,000
-16.0%
8,0000.0%0.09%
-15.3%
Q2 2017$858,000
-0.1%
8,0000.0%0.11%
-4.3%
Q1 2017$859,000
-1.9%
8,0000.0%0.12%
-10.1%
Q4 2016$876,000
-8.3%
8,0000.0%0.13%
-9.2%
Q3 2016$955,000
-4.8%
8,0000.0%0.14%
-13.4%
Q2 2016$1,003,000
-3.7%
8,0000.0%0.16%
-9.4%
Q1 2016$1,041,0008,0000.18%
Other shareholders
TEVA PHARMACEUTICAL FIN LLC shareholders Q1 2018
NameSharesValueWeighting ↓
Southpaw Asset Management LP 20,000,000$17,675,00025.38%
INCOME RESEARCH & MANAGEMENT 23,109,000$20,278,0005.29%
Fore Capital, LLC 5,000,000$4,430,0001.71%
RIVERHEAD CAPITAL MANAGEMENT LLC 20,000,000$17,603,0000.74%
ARISTEIA CAPITAL, L.L.C. 18,500,000$16,361,0000.70%
ZAZOVE ASSOCIATES LLC 11,153,000$9,843,0000.58%
BASSO CAPITAL MANAGEMENT, L.P. 3,600,000$3,182,0000.52%
CSS LLC/IL 10,450,000$9,240,0000.45%
Lombard Odier Asset Management (Europe) Ltd 7,950,000$7,038,0000.44%
Wellesley Asset Management 6,740$5,948,0000.31%
View complete list of TEVA PHARMACEUTICAL FIN LLC shareholders